A Randomized Double Blind Phase II Trial of Platinum Therapy plus Etoposide with/without Concurrent ZD6474 in Patients with Previously Untreated Extensive Stage Small Cell Lung Cancer: Hoosier Oncology Group LUN06-113.
Phase of Trial: Phase II
Latest Information Update: 01 Sep 2016
At a glance
- Drugs Vandetanib (Primary) ; Carboplatin; Cisplatin; Etoposide
- Indications Non-small cell lung cancer
- Focus Pharmacogenomic; Therapeutic Use
- 31 Aug 2018 Biomarkers information updated
- 01 Sep 2016 Results assessing addition of Vandetanib to platinum and etoposide on outcomes of the study published in the Cancer (2016).
- 17 Nov 2015 Status changed from active, no longer recruiting to completed, according to ClinicalTrials.gov record.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History